OraSure Technologies Inc. (OSUR)
| Bid | 2.83 |
| Market Cap | 230.53M |
| Revenue (ttm) | 108.77M |
| Net Income (ttm) | -8.72M |
| EPS (ttm) | -0.26 |
| PE Ratio (ttm) | -11.44 |
| Forward PE | -8.04 |
| Analyst | Hold |
| Ask | 3.1 |
| Volume | 532,917 |
| Avg. Volume (20D) | 861,136 |
| Open | 2.91 |
| Previous Close | 2.92 |
| Day's Range | 2.90 - 3.01 |
| 52-Week Range | 2.69 - 5.59 |
| Beta | 0.77 |
About OSUR
OraSure Technologies, Inc., together with its subsidiaries, develops, manufactures, markets, and sells oral fluid diagnostic products and specimen collection devices in the United States, Europe, and internationally. It operates in two segments, Diagnostics and Molecular Solutions. The company's principal products include InteliSwab COVID-19 rapid test, InteliSwab COVID-19 rapid test pro, InteliSwab COVID-19 rapid test rx, OraQuick Rapid HIV test...
Analyst Forecast
According to 2 analyst ratings, the average rating for OSUR stock is "Hold." The 12-month stock price forecast is $5.5, which is an increase of 84.87% from the latest price.
Stock ForecastsNext Earnings Release
Analysts project revenue of ... Unlock content with Pro Subscription
1 month ago · seekingalpha.com
OraSure Technologies, Inc. (OSUR) Q4 2024 Earnings Call TranscriptOraSure Technologies, Inc. (NASDAQ:OSUR ) Q4 2024 Results Conference Call February 25, 2025 5:00 PM ET Company Participants Jason Plagman - VP of Investor Relations Carrie Eglinton Manner - President ...
